
CalciMedica, Inc. Common Stock
CALC
CALC: CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.
moreShow CALC Financials
Recent trades of CALC by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CALC's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Pyrazine-containing compound Sep. 13, 2022
-
Patent Title: Pancreatitis treatment Apr. 26, 2022
-
Patent Title: Pyrazine-containing compound Apr. 13, 2021
-
Patent Title: Pyrazine-containing compound Nov. 03, 2020
-
Patent Title: Compounds that modulate intracellular calcium Jul. 07, 2020
-
Patent Title: Use of crac channel inhibitors for the treatment of stroke and traumatic brain injury Nov. 19, 2019
-
Patent Title: Use of crac channel inhibitors for the treatment of stroke and traumatic brain injury Sep. 24, 2019
-
Patent Title: Compounds that modulate intracellular calcium Jul. 02, 2019
-
Patent Title: Compounds that modulate intracellular calcium Jan. 02, 2018
-
Patent Title: Compounds that modulate intracellular calcium Apr. 04, 2017
-
Patent Title: Compounds that modulate intracellular calcium Dec. 06, 2016
-
Patent Title: Compounds that modulate intracellular calcium May. 31, 2016
-
Patent Title: Compounds that modulate intracellular calcium Sep. 01, 2015
-
Patent Title: Compounds that modulate intracellular calcium Jul. 28, 2015
-
Patent Title: Compounds that modulate intracellular calcium Jul. 14, 2015
-
Patent Title: Compounds that modulate intracellular calcium Mar. 17, 2015
-
Patent Title: Compounds that modulate intracellular calcium Jun. 17, 2014
-
Patent Title: Compounds that modulate intracellular calcium Dec. 31, 2013
-
Patent Title: Compounds that modulate intracellular calcium Oct. 01, 2013
-
Patent Title: Compounds that modulate intracellular calcium Sep. 03, 2013
-
Patent Title: Inhibitors of store operated calcium release Sep. 03, 2013
-
Patent Title: Calcium channel proteins and uses thereof Aug. 13, 2013
-
Patent Title: Compounds that modulate intracellular calcium Mar. 12, 2013
-
Patent Title: Compounds that modulate intracellular calcium Mar. 05, 2013
-
Patent Title: Trisubstituted thiophenes that modulate intracellular calcium Feb. 26, 2013
-
Patent Title: Trisubstituted thiophenes that modulate intracellular calcium Feb. 12, 2013
-
Patent Title: Methods of modulating and identifying agents that modulate intracellular calcium Dec. 04, 2012
-
Patent Title: Compounds that modulate intracellular calcium Sep. 11, 2012
-
Patent Title: Inhibitors of store operated calcium release Mar. 27, 2012
-
Patent Title: Compounds that modulate intracellular calcium Jul. 19, 2011
-
Patent Title: Substituted thiophene modulators of intracellular calcium Mar. 15, 2011
-
Patent Title: Methods of modulating and identifying agents that modulate intracellular calcium Oct. 26, 2010
-
Patent Title: Composition comprising a cell comprising a stim1 protein and an agent that modulates intracellular calcium and methods of use Jan. 12, 2010
Federal grants, loans, and purchases
Followers on CALC's company Twitter account
Number of mentions of CALC in WallStreetBets Daily Discussion
Recent insights relating to CALC
Recent picks made for CALC stock on CNBC
ETFs with the largest estimated holdings in CALC
Flights by private jets registered to CALC